E
Hinge Health, Inc. HNGE
$40.91 -$1.20-2.85% NYSE
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

Company Overview

Hinge Health, Inc. is a digital health technology company operating in the musculoskeletal (MSK) care, digital physical therapy, and pain management industries. The company provides a software-enabled, clinically guided platform designed to help individuals manage acute and chronic musculoskeletal conditions, such as back pain, joint pain, and post-surgical rehabilitation. Its core offering combines wearable sensor technology, computer vision, and personalized exercise therapy with access to human clinicians, including physical therapists and health coaches.

The company primarily serves employers, health plans, and government-sponsored health programs, positioning itself as a cost-containment and outcomes-improvement solution for high-spend MSK conditions. Hinge Health emphasizes a non-surgical, non-opioid approach to care, which it positions as a strategic advantage amid rising healthcare costs. Founded in 2014, the company has evolved from a digital physical therapy startup into a broader MSK care platform, expanding its services to include surgery optimization and post-operative recovery programs.

Business Operations

Hinge Health generates revenue primarily through subscription-based contracts with employers and health plans, typically structured on a per-member-per-month or outcomes-based pricing model. Its core business is organized around integrated digital care programs that combine proprietary software, FDA-listed wearable sensors, and access to licensed clinicians. These programs are delivered through the company’s mobile application and cloud-based platform, which track patient adherence, movement accuracy, and clinical outcomes.

Operations are largely centralized in the United States, where the company delivers care through a distributed network of clinicians licensed across multiple states. Hinge Health controls its core technology platform and analytics capabilities internally while partnering with healthcare providers and payer organizations for distribution. The company operates as a standalone entity and does not publicly disclose material joint ventures; information on subsidiaries is limited, and data inconclusive based on available public sources.

Strategic Position & Investments

Strategically, Hinge Health focuses on expanding its role as a comprehensive MSK care partner by moving upstream into prevention and downstream into surgery decision support and recovery. Growth initiatives have included broadening clinical offerings, investing in artificial intelligence and computer vision to automate motion tracking, and expanding employer and payer adoption through multi-year enterprise contracts. The company has emphasized clinical validation and outcomes reporting as a differentiator in competitive enterprise healthcare sales cycles.

Hinge Health has completed multiple venture funding rounds backed by institutional investors and has used capital primarily for technology development, clinical expansion, and go-to-market scaling. It has also pursued targeted acquisitions to enhance its care continuum, most notably the acquisition of Enso, a wearable pain relief technology company, to integrate neuromodulation into its MSK platform. Public disclosures regarding additional portfolio investments are limited, and data inconclusive based on available public sources.

Geographic Footprint

Hinge Health is headquartered in the United States, with its principal executive offices located in California. The company’s customer base is predominantly U.S.-focused, reflecting the structure of employer-sponsored health insurance and domestic MSK healthcare spending. Clinical services are delivered nationwide through licensed providers, giving the company operational reach across most U.S. states.

International operations remain limited. While the company has explored international expansion opportunities and employs staff in select global locations, there is no verified evidence of large-scale commercial MSK program deployment outside the U.S. Market presence beyond North America is minimal based on available public disclosures.

Leadership & Governance

Hinge Health was co-founded by Daniel Perez, who continues to play a central role in shaping the company’s strategy and mission around accessible, non-invasive MSK care. The leadership team emphasizes a data-driven, outcomes-focused philosophy, integrating clinical rigor with consumer-grade digital experiences. Governance is characteristic of a late-stage private technology company, with board oversight that includes founder representation and institutional investors.

Key executives include:

  • Daniel PerezChief Executive Officer
  • Gabriel MecklenburgCo-Founder and President
  • Monica Wright RogersChief Revenue Officer
  • Nima JalaliChief Technology Officer
  • Elizabeth FredianiChief People Officer
  • Trent GreenChief Financial Officer
Data complied by narrative technology. May contain errors

Top Tech Stocks
See All »
B
NVDA NASDAQ $175.20
B
AAPL NASDAQ $251.64
B
MSFT NASDAQ $372.64
Top Consumer Staple Stocks
See All »
B
WMT NASDAQ $122.05
B
Top Financial Stocks
See All »
B
B
JPM NYSE $292.40
B
V NYSE $303.88
Top Energy Stocks
See All »
B
ENB.TO TSX $73.47
B
ENB NYSE $54.44
Top Health Care Stocks
See All »
B
LLY NYSE $903.00
B
JNJ NYSE $235.27
B
AMGN NASDAQ $348.43
Top Real Estate Stocks
See All »
B
PLD NYSE $130.35